Abstract
Lawrence R. Deyton, MSPH, MDa The 2009 passage of the Family Smoking Prevention and Tobacco Control Act launched the most far-reaching public health intervention in a generation.1 For the first time ever, the U.S. Food and Drug Administration (FDA) is fully authorized to use its regulatory authority to combat the nation's leading cause of preventable death: tobacco. However, FDA regulation is not only a powerful new tool to reduce tobacco-related disease and death, it also poses new opportunities and challenges to public health practitioners at every level of government, academia, research, and advocacy. It is difficult to overstate the human and economic cost of tobacco use in the
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
